Condition · ICD-10 B18.2

Hepatitis C

Chronic HCV Infection

A viral liver infection caused by the hepatitis C virus that can lead to chronic liver disease, cirrhosis, and liver cancer if untreated.

Hepatitis C affects approximately 2.4 million Americans, most of whom are unaware of their infection. Direct-acting antiviral (DAA) regimens now achieve cure rates exceeding 95% with 8–12 weeks of oral therapy and minimal side effects. Screening is recommended for all adults born between 1945–1965 and for those with risk factors.

At a glance
Medications tracked
5
First-line options
Ledipasvir-Sofosbuvir, Sofosbuvir-Velpatasvir, Glecaprevir-Pibrentasvir
Related conditions
Hepatitis BLiver CirrhosisLiver CancerHIV/AIDS

First-line Related Treatments

Commonly associated primary options — verify with your clinician

Primary options
Ledipasvir-Sofosbuvir
Ledipasvir-Sofosbuvir
Rx
Tablet
Strength 90 mg-400 mg
NDC 61958-1901-1
Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir
Rx
Tablet
Strength 400 mg-100 mg
NDC 61958-2501-1
Glecaprevir-Pibrentasvir
Glecaprevir-Pibrentasvir
Rx
Tablet
Strength 100 mg-40 mg
NDC 0074-3165-28

Situational

Related options for specific presentations

Specific presentations
Ribavirin
Ribavirin
Rx
Tablet
Strength 200 mg
NDC 0093-0898-56
Elbasvir-Grazoprevir
Elbasvir-Grazoprevir
Rx
Tablet
Strength 50 mg-100 mg
NDC 0006-3107-28

Top treatments tried for Hepatitis C

Community-driven data · early preview

Ledipasvir-Sofosbuvir
1,800 people tried
4.3
Sofosbuvir-Velpatasvir
1,520 people tried
4.1
Glecaprevir-Pibrentasvir
1,240 people tried
4.0
Help build the dataset — log treatments you've tried, rate what helped, and report side effects.